NAD<sup>+</sup>-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin

Dongjie Li, Jiang‐Tao Fu, Shen‐Xi Ouyang, Qin-Jie Zhao, Li Su, Qing-Xi Ji, Di-Ynag Sun, Jiahui Zhu, Guo‐Yan Zhang, Jiawei Ma,

Theranostics · 2021 · 83 citations · 1 references

DOIFull text

Open access

Concepts

Abstract

-boosting therapy in metabolic pathophysiology.

References

1